Interpreting D-Dimer and Fibrin(ogen) Degradation Products in Hemodialysis Vascular Access Surveillance
Blood Purification · 24.04.2026 · 1-9
DOI: 10.1159/000552076 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Blood Purification, online erschienen am 24.04.2026. Verfasst von Min Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Weifang People's Hospital, Shandong Second Medical University, Weifang, China. Die Arbeit nennt 41 Literaturangaben.
Abstract (Originalsprache)
Background: Vascular access dysfunction remains a major source of morbidity and repeat procedures in maintenance hemodialysis (HD), with thrombosis as a key proximate event. D-dimer and fibrin(ogen) degradation products (FDPs) are widely available readouts of downstream fibrin(ogen) turnover, but they are not routinely used for access surveillance and are often difficult to interpret in HD. Summary: This narrative review summarizes HD-specific biology relevant to fibrin turnover and synthesizes clinical evidence linking D-dimer and FDP to access outcomes across arteriovenous fistulas, grafts, and catheters. HD promotes a prothrombotic, hypofibrinolytic profile through uremia-related endothelial disturbance, chronic inflammation, and extracorporeal circuit effects. The clinical literature is mostly small and heterogeneous in assay platforms, sampling, and outcome definitions. Across cohorts, repeated pre-dialysis measurements may provide more interpretable within-patient context than single measurements, although longitudinal HD access-specific evidence remains limited. Interpretation remains constrained by assay and unit variability and by non-access-related influences such as inflammation and intercurrent illness. Accordingly, D-dimer and FDP are best used as contextual adjuncts within an imaging- and hemodynamics-based framework, interpreted alongside access flow measures, duplex ultrasound, and clinical assessment. Key Messages: In HD access, repeated pre-dialysis measurements may provide more interpretable within-patient context than one-off D-dimer/FDP values, although direct longitudinal evidence remains limited. Assay and unit heterogeneity, plus systemic confounding, limit portability and access-specific interpretation. Biomarkers are best read as supportive context alongside hemodynamic measures and clinical assessment, not as stand-alone surveillance tools. Imaging-anchored prospective studies with standardized sampling and explicit assay/unit reporting are needed to define added value.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Weifang People's Hospital, Shandong Second Medical University, Weifang, China.
- Nephrology Medical Centre, Weifang People's Hospital, Shandong Second Medical University, Weifang, China.
- Nephrology Medical Centre, Weifang People's Hospital, Shandong Second Medical University, Weifang, China, sunxinran163@163.com.
Zitieren
APA
Li, M., Fan, X., Du, X., Li, A., Zhao, Z., & Du, J. (2026). Interpreting D-Dimer and Fibrin(ogen) Degradation Products in Hemodialysis Vascular Access Surveillance. Blood Purification, 1-9. https://doi.org/10.1159/000552076
Vancouver
Li M, Fan X, Du X, Li A, Zhao Z, Du J. Interpreting D-Dimer and Fibrin(ogen) Degradation Products in Hemodialysis Vascular Access Surveillance. Blood Purification. 2026:1-9. doi:10.1159/000552076
BibTeX
@article{Li2026,
author = {Li, Min and Fan, Xiaoli and Du, Xinru and Li, Aihui and Zhao, Zhanyun and Du, Jing},
title = {Interpreting D-Dimer and Fibrin(ogen) Degradation Products in Hemodialysis Vascular Access Surveillance},
journal = {Blood Purification},
year = {2026},
pages = {1--9},
doi = {10.1159/000552076}
}
EUVIMED